The Neuropathology of Progressive Multiple Sclerosis
N Evangelou, SML Paine, EC Tallantyre - Progressive multiple sclerosis, 2018 - Springer
… sclerosis. What is often referred to as the normal appearing white matter in MRI studies, can
be demonstrated to possess features of disease … subtypes of multiple sclerosis. In particular, …
be demonstrated to possess features of disease … subtypes of multiple sclerosis. In particular, …
The neuropathology of progressive multiple sclerosis
L Bo, N Evangelou, E Tallantyre - Progressive Multiple Sclerosis, 2013 - Springer
… These pale areas are sometimes referred to as “shadow plaques.” At least some such
areas are likely to represent areas of remyelination [17]. Pathology studies indicate that …
areas are likely to represent areas of remyelination [17]. Pathology studies indicate that …
Elucidating the functions of fibroblast growth factor 9 in multiple sclerosis
D McElroy - 2018 - theses.gla.ac.uk
… Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system.
In around 85% of cases, the disease progresses through two distinct stages: relapsing-remitting …
In around 85% of cases, the disease progresses through two distinct stages: relapsing-remitting …
Chronic cortical pathology in multiple sclerosis: molecular studies on normal-appearing and demyelinated cortex and a novel animal model for chronic inflammatory …
LS Enz - 2020 - edoc.unibas.ch
… After the acute demyelinating phase, the lesions can develop into gliotic scar tissue (sclerosis),
and become chronic active or inactive lesions or they may remyelinate to form shadow …
and become chronic active or inactive lesions or they may remyelinate to form shadow …
Biophysical methods for disease monitoring in dermatology
P Elsner, AO Barel, E Berardesca… - … and Applications in …, 1998 - books.google.com
… Using A mode ultrasound, Serup [14], showed that plaques of clinically advanced scleroderma
were thicker than plaques of slight scleroderma. The relative increase in thickness was …
were thicker than plaques of slight scleroderma. The relative increase in thickness was …
Immune-mediated oligodendrocyte injury in multiple sclerosis: molecular mechanisms and therapeutic interventions
M Buntinx, P Stinissen, P Steels… - Critical Reviews™ in …, 2002 - dl.begellhouse.com
… ABSTRACT: In this review, new insights into the immunopathogenesis of multiple
sclerosis (MS) are discussed, with special focus on the potential mechanisms leading to …
sclerosis (MS) are discussed, with special focus on the potential mechanisms leading to …
Axonopathy and cytoskeletal disruption in degenerative diseases of the central nervous system
… conditions – amyotrophic lateral sclerosis, multiple sclerosis and Alzheimer's disease – with
emphasis on key cellular changes that may underlie early axonal dysfunction and pathology …
emphasis on key cellular changes that may underlie early axonal dysfunction and pathology …
Super-resolving microscopy in neuroscience
… disorders of the CNS can very roughly be subdivided into diseases that are mainly mediated
by deregulated cellular immune response, eg multiple sclerosis, by pathological humoral …
by deregulated cellular immune response, eg multiple sclerosis, by pathological humoral …
Ramifications of microglial activation on oligodendrocytes in in vitro models of multiple sclerosis
I Sevastou - 2010 - discovery.ucl.ac.uk
Oligodendrocytes are the principal target of immune attack in multiple sclerosis (… could
prevent microglial induced oligodendrocyte toxicity and could lead to strategies to slow disease …
prevent microglial induced oligodendrocyte toxicity and could lead to strategies to slow disease …
Cutaneous deposits
AM Molina-Ruiz, L Cerroni, H Kutzner… - The American Journal …, 2014 - journals.lww.com
… occur in systemic scleroderma. Calcinosis cutis in localized … Werner syndrome is an inherited
disorder that leads to … These processes usually occur on the aggregates of shadow cells. …
disorder that leads to … These processes usually occur on the aggregates of shadow cells. …